Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study

K. W. Rammohan, J. H. Rosenberg, D. J. Lynn, A. M. Blumenfeld, C. P. Pollak, H. N. Nagaraja

Research output: Contribution to journalArticlepeer-review

373 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences